EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY-NC 4.0

Efficacy of Teduglutide for Pediatric and Short Bowel Syndrome-Associated Intestinal Failure: A Systematic Review

Matheus Barros de Albuquerque, Carla Montenegro Dias, Diogo Grassano Melo Ferreira, Joao Victor de Oliveira Maldonado, Mateus Macedo Margato, Luiz Eduardo Duarte Borges Nunes, Emanuel Savio Cavalcanti Sarinho, Lucia Helena Oliveira Cordeiro, Luiz Alberto Reis Mattos, Amanda Catriona Fifi

International Journal of Clinical Pediatrics · 2026-03 · 15 (1) · 8-15

DOI: 10.14740/ijcp1039 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift International Journal of Clinical Pediatrics, 2026-03. Verfasst von Matheus Barros de Albuquerque und 9 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Intestinal failure secondary to short bowel syndrome (SBS) is a severe malabsorptive condition often requiring long-term parenteral nutrition (PN). Teduglutide, a glucagon-like peptide-2 (GLP-2) analogue, promotes intestinal adaptation and may reduce PN dependence. This systematic review evaluated the efficacy of teduglutide in reducing PN requirements in pediatric patients with intestinal failure.

Methods

Clinical studies evaluating teduglutide therapy in pediatric patients with intestinal failure secondary to SBS were included. Randomized trials, non-randomized studies, and post-hoc analysis of clinical trials were considered due to the limited number of pediatric studies available. Risk of bias was assessed using the RoB-2 (Cochrane) tool, and statistical analyses were performed using Review Manager 5.4.1.

Results

Teduglutide therapy was associated with a significantly higher likelihood of achieving a clinically meaningful ≥ 20% reduction in PN volume compared with standard of care (odds ratio 11.79; 95% confidence interval, 2.04–68.24; P = 0.006). Treatment was also associated with improvement in length/height-for-age z-score, while no significant difference was observed in weight-for-length z-score.

Conclusion

Findings support teduglutide as an effective therapeutic option to reduce PN dependence and promote progression toward enteral nutrition autonomy in pediatric patients with SBS-associated intestinal failure.

Zitieren

APA

Albuquerque, M. B. D., Dias, C. M., Ferreira, D. G. M., Maldonado, J. V. D. O., Margato, M. M., Nunes, L. E. D. B., Sarinho, E. S. C., Cordeiro, L. H. O., Mattos, L. A. R., & Fifi, A. C. (2026). Efficacy of Teduglutide for Pediatric and Short Bowel Syndrome-Associated Intestinal Failure: A Systematic Review. International Journal of Clinical Pediatrics, 15(1), 8-15. https://doi.org/10.14740/ijcp1039

Vancouver

Albuquerque MBD, Dias CM, Ferreira DGM, Maldonado JVDO, Margato MM, Nunes LEDB, et al. Efficacy of Teduglutide for Pediatric and Short Bowel Syndrome-Associated Intestinal Failure: A Systematic Review. International Journal of Clinical Pediatrics. 2026;15(1):8-15. doi:10.14740/ijcp1039

BibTeX
@article{Albuquerque2026,
  author = {Albuquerque, Matheus Barros de and Dias, Carla Montenegro and Ferreira, Diogo Grassano Melo and Maldonado, Joao Victor de Oliveira and Margato, Mateus Macedo and Nunes, Luiz Eduardo Duarte Borges and Sarinho, Emanuel Savio Cavalcanti and Cordeiro, Lucia Helena Oliveira and Mattos, Luiz Alberto Reis and Fifi, Amanda Catriona},
  title = {Efficacy of Teduglutide for Pediatric and Short Bowel Syndrome-Associated Intestinal Failure: A Systematic Review},
  journal = {International Journal of Clinical Pediatrics},
  year = {2026},
  volume = {15},
  number = {1},
  pages = {8--15},
  doi = {10.14740/ijcp1039}
}
Kostenlos starten →